The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.
Nov 25, 2012
0
0
An experiment carried out on rodents exposed to fuel similar to that of the Prestige tanker oil spill – which took place nearly a decade ago – shows that inhalation of the fuel causes damage to genetic material. According ...
Oct 15, 2012
0
0
(HealthDay)—As a nationwide outbreak of steroid-linked meningitis grabs headlines, health officials in New York City say a separate, unrelated outbreak is hitting gay and bisexual men.
Oct 11, 2012
0
0
Healthcare professionals are as bad as patients when it comes to knowing how to use inhalers prescribed for asthma and other respiratory conditions correctly, says an editorial in Drug and Therapeutics Bulletin (DTB).
Oct 3, 2012
0
0
Smoke poisoning can be caused by a number of things, including cyanides, the salts of hydrocyanic acid. Because the quick diagnosis and treatment of victims with cyanide poisoning is critical and often lifesaving, it is very ...
Sep 4, 2012
0
0
Details of a treatment that could help asthmatics fight infections that trigger 80% of asthma attacks, developed by University of Southampton spin-out company Synairgen, will be presented to European respiratory experts on ...
Aug 31, 2012
0
0
Water-pipe smoking is as bad as deeply inhaling cigarette smoke when it comes to causing respiratory problems, according to a study published on Thursday.
Aug 30, 2012
0
0
(HealthDay)—It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests.
Aug 27, 2012
0
0
New research from the Monell Center reveals that exposure to secondhand smoke decreases sensitivity to cough-eliciting respiratory irritants in otherwise healthy children and adolescents. The findings may help to explain ...
Aug 20, 2012
0
0
(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) ...
Jul 24, 2012
0
1
